IMM - Immutep Limited
ASX
->
Healthcare
->
Biotechnology
Sydney,
Australia
Type: Equity
IMM price evolution
IMM
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $103.73 | $103.73 | $123.42 | $123.42 |
| Short term investments | ||||
| Net receivables | $6.1 | $6.1 | $7.97 | $7.97 |
| Inventory | ||||
| Total current assets | $113.04 | $113.04 | $134.97 | $134.97 |
| Long term investments | ||||
| Property, plant & equipment | $0.8 | $0.8 | $0.47 | $0.47 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $123.79 | $123.79 | $147.45 | $147.45 |
| Current liabilities | ||||
| Accounts payable | $5.87 | $5.87 | $5.45 | $5.45 |
| Deferred revenue | ||||
| Short long term debt | $0.21 | $0.21 | $0.18 | $0.18 |
| Total current liabilities | $6.56 | $6.56 | $9.77 | $9.77 |
| Long term debt | $1.4 | $1.4 | $1.04 | $1.04 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $8.15 | $8.15 | $10.98 | $10.98 |
| Shareholders' equity | ||||
| Retained earnings | -$361.16 | -$361.16 | -$339.93 | -$339.93 |
| Other shareholder equity | $30.09 | $30.09 | $39.79 | $39.79 |
| Total shareholder equity | $115.64 | $115.64 | $136.47 | $136.47 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | 30 Jun 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $123.42 | $80 | $60.13 | $26.32 |
| Short term investments | ||||
| Net receivables | $7.97 | $8.37 | $6.12 | $3.39 |
| Inventory | ||||
| Total current assets | $134.97 | $90.81 | $68.42 | $31.15 |
| Long term investments | ||||
| Property, plant & equipment | $0.47 | $0.31 | $0.31 | $0.25 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $147.45 | $102.17 | $82.03 | $46.6 |
| Current liabilities | ||||
| Accounts payable | $5.45 | $2.87 | $1.82 | $1.64 |
| Deferred revenue | ||||
| Short long term debt | $0.18 | $0.17 | $0.21 | $0.13 |
| Total current liabilities | $9.77 | $6.41 | $5.34 | $3.36 |
| Long term debt | $1.04 | $1.56 | $2.61 | $8.92 |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $10.98 | $8.09 | $8.76 | $13.3 |
| Shareholders' equity | ||||
| Retained earnings | -$339.93 | -$302.34 | -$251.68 | -$252.88 |
| Other shareholder equity | $39.79 | $38.67 | $11.53 | $43.19 |
| Total shareholder equity | $136.47 | $94.08 | $73.27 | $33.3 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.06 | $2.06 | $0.91 | $0.91 |
| Cost of revenue | $8.64 | $8.64 | ||
| Gross Profit | $2.06 | $2.06 | -$7.73 | -$7.73 |
| Operating activities | ||||
| Research & development | $10.22 | $10.22 | $4.91 | $4.91 |
| Selling, general & administrative | $2.4 | $2.4 | $2.27 | $2.27 |
| Total operating expenses | $12.62 | $12.62 | $10.92 | $10.92 |
| Operating income | -$10.56 | -$10.56 | -$10.01 | -$10.01 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.01 | -$0.01 | -$0 | -$0 |
| Net income | ||||
| Net income | -$10.61 | -$10.61 | -$9.64 | -$9.64 |
| Income (for common shares) | -$10.61 | -$10.61 | -$9.64 | -$9.64 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.51 | $4.71 | $3.86 | |
| Cost of revenue | $36.26 | $31.34 | $17.24 | |
| Gross Profit | -$32.75 | -$26.63 | -$13.37 | |
| Operating activities | ||||
| Research & development | $28.79 | $25.34 | $12.02 | |
| Selling, general & administrative | $8.68 | $7.21 | $6.28 | |
| Total operating expenses | $44.94 | $38.55 | $23.52 | |
| Operating income | -$41.43 | -$33.84 | -$19.66 | |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.02 | -$0.09 | -$0.01 | |
| Net income | ||||
| Net income | -$39.9 | -$32.21 | -$29.9 | |
| Income (for common shares) | -$39.9 | -$32.21 | -$29.9 | |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$10.61 | -$10.61 | -$9.64 | -$9.64 |
| Operating activities | ||||
| Depreciation | $0.12 | $0.12 | ||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$9.23 | -$9.23 | -$11.72 | -$11.72 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.01 | -$0 | -$0 |
| Investments | ||||
| Total cash flows from investing | -$0.21 | -$0.21 | -$0.01 | -$0.01 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $40.04 | $40.04 | ||
| Net borrowings | -$0.06 | -$0.06 | -$0.05 | -$0.05 |
| Total cash flows from financing | -$0.22 | -$0.22 | $38.07 | $38.07 |
| Effect of exchange rate | -$0.01 | -$0.01 | $0.08 | $0.08 |
| Change in cash and equivalents | -$9.84 | -$9.84 | $27.52 | $27.52 |
| (in millions $) | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | |
|---|---|---|---|---|
| Net income | -$39.9 | -$32.21 | -$29.9 | |
| Operating activities | ||||
| Depreciation | $0.24 | $0.25 | $2.07 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$35.36 | -$30.23 | -$17.64 | |
| Investing activities | ||||
| Capital expenditures | -$0.08 | -$0.02 | -$0.02 | |
| Investments | ||||
| Total cash flows from investing | -$0.08 | -$0.02 | -$0.02 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $80.08 | $52.98 | $55.04 | |
| Net borrowings | -$0.21 | -$0.22 | -$0.21 | |
| Total cash flows from financing | $76.02 | $50.33 | $52.68 | |
| Effect of exchange rate | $0.62 | $1.23 | -$0.51 | |
| Change in cash and equivalents | $43.42 | $19.4 | $34.27 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $5.94M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$40.50M |
| Revenue Q/Q | 94.34% |
| Revenue Y/Y | 24.79% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -29.86% |
| ROE | -32.13% |
| Debt/Equity | 0.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 17.23 |
| Quick ratio | N/A |